Orally adhering lozenges containing soluble dietary fiber
Orally adhering lozenges comprising soluble dietary fiber are provided herein. The orally adhering lozenges provided herein may be in the form of tablet-type lozenges comprising compressed powders and/or granules in at least two layers. The orally adhering lozenges include at least 30% soluble dietary fiber. The orally adhering lozenges also include an adhesive component to adhere the lozenge inside the mouth. The orally adhering lozenges are also low in cariogenic sugar, non-resistant starch, and polyols.
1. An orally adhering lozenge for release of a target component in the mouth, the lozenge comprising at least two layers formed of compressed powders, the lozenge comprising:
an adherent layer comprising an adhesive component; and
a non-adherent layer comprising a mixture of at least 60% soluble dietary fiber by weight of the non-adherent layer and a target component,
wherein the lozenge comprises at least 30% soluble dietary fiber by weight of the lozenge when analyzed by AOAC method 991.43.
2. The orally adhering lozenge of claim 1 , wherein the lozenge comprises at least 40% soluble dietary fiber by weight of the lozenge when analyzed by AOAC method 991.43.
3. The orally adhering lozenge of claim 1 , comprising less than 4% cariogenic sugar by weight of the lozenge when analyzed by AOAC method 982.14.
4. The orally adhering lozenge of claim 1 , comprising less than 2% cariogenic sugar by weight of the lozenge when analyzed by AOAC method 982.14.
5. The orally adhering lozenge of claim 1 , comprising less than 30% polyol by weight of the lozenge when analyzed by AOAC method 982.14.
6. The orally adhering lozenge of claim 1 , comprising less than 20% polyol by weight of the lozenge when analyzed by AOAC method 982.14.
7. The orally adhering lozenge of claim 1 , comprising less than 4% cariogenic sugar and less than 30% polyol by weight of the lozenge when analyzed by AOAC method 982.14.
8. The orally adhering lozenge of claim 1 , wherein the adhesive component comprises one or more of acacia gum, gelatin, gum Arabic, alginate, starch, pectin, polyvinyl acid, polyvinylpyrrolidone, carboxymethylcellulose (CMC), hydroxymethylcellulose, polyacrylic acid, and carbomer.
9. The orally adhering lozenge of claim 1 , wherein the soluble dietary fiber comprises one or more of dextrin, resistant dextrin, resistant maltodextrin, inulin, enzyme resistant starch, enzyme resistant modified starch, polydextrose, psyllium, non-starch polysaccharide, polycarbophil, chitin, pectin, guar gum, partially hydrolyzed guar gum, locust bean gum, carrageenan, xanthan gum, konjac gum, beta-glucan, oligosaccharide, and fructooligosaccharide.
10. The orally adhering lozenge of claim 1 , wherein the target component comprises one or more of a flavor and an active pharmaceutical ingredient.
11. The orally adhering lozenge of claim 1 , wherein the target component comprises one or more of a flavor, antibiotic, anesthetic, analgesic, antiviral, aspirin, anti-inflammatory, antacid, cannabidiol, antifungal, nicotine, caffeine, chamomile, hyaluronan, vitamin, mineral, plant extract, and herbal supplement.
12. The orally adhering lozenge of claim 1 , further comprising one or more of a lubricant, pH adjusting agent, and binder.
13. A method of preparing a bilayer lozenge for the oral release of a target component, the method comprising:
forming a first powder mixture;
placing the first powder mixture in a die;
inserting an upper punch into the die and pressing the upper punch to compress the first powder to form a first layer of compressed powder;
forming a second powder mixture;
placing the second powder mixture into the die on top of the first layer of compressed powder and pressing the upper punch to compress the second powder mixture to form a bilayer lozenge,
wherein either the first or second powder mixture comprises a combination of at least 60% soluble dietary fiber by weight of the powder mixture and at least one target component, and the other of the first or second powder mixture comprises an adhesive component,
wherein the bi-layer lozenge includes at least 30% soluble dietary fiber by weight of the lozenge when analyzed by AOAC method 991.43.
14. The method of claim 13 , wherein the bilayer lozenge comprises at least 40% soluble dietary fiber by weight of the lozenge when analyzed by AOAC method 991.43.
15. The method of claim 13 , wherein the bilayer lozenge comprises less than 4% cariogenic sugar by weight of the lozenge when analyzed by AOAC method 982.14.
16. The method of claim 13 , wherein the bilayer lozenge comprises less than 2% cariogenic sugar by weight of the lozenge when analyzed by AOAC method 982.14.
17. The method of claim 13 , wherein the bi-layer lozenge comprises less than 30% polyol by weight of the lozenge when analyzed by AOAC method 982.14.
18. The method of claim 13 , wherein the soluble dietary fiber comprises one or more of dextrin, resistant dextrin, resistant maltodextrin, inulin, enzyme resistant starch, enzyme resistant modified starch, polydextrose, psyllium, non-starch polysaccharide, polycarbophil, chitin, pectin, guar gum, partially hydrolyzed guar gum, locust bean gum, carrageenan, xanthan gum, konjac gum, beta-glucan, oligosaccharide, and fructooligosaccharide.
19. An orally adhering lozenge for release of a target component in the mouth, the lozenge comprising at least two layers, the lozenge comprising:
an adherent layer comprising an adhesive component; and
a non-adherent layer comprising a mixture of at least 60% soluble dietary fiber by weight of the non-adherent layer and a target component,
wherein the lozenge comprises at least 30% soluble dietary fiber by weight of the lozenge when analyzed by AOAC method 991.43, and
wherein the soluble dietary fiber comprises one or more of dextrin, resistant dextrin, resistant maltodextrin, inulin, enzyme resistant starch, enzyme resistant modified starch, polydextrose, psyllium, non-starch polysaccharide, polycarbophil, chitin, pectin, partially hydrolyzed guar gum, beta-glucan, oligosaccharide, and fructooligosaccharide.
20. The orally adhering lozenge of claim 19 , wherein the soluble dietary fiber comprises one or more of dextrin, partially hydrolyzed guar gum, inulin, and beta-glucan.